Metagenomic next-generation sequencing as an emerging modality for the diagnosis of infectious diseases

A recent study published in the Open Forum Infectious Diseases Journal examined the role of plasma metagenomic next-generation sequencing (mNGS), a promising method for detecting infectious illnesses. Study: Impact of metagenomic next-generation sequencing of plasma cell-free DNA testing in the management of patients with suspected infectious diseases. Image Credit: ArtemisDiana/Shutterstock.com Background The ability to rapidly identify human pathogens in clinical samples has […]

Continue reading »

New study reveals global anemia cases remain persistently high among women and children

Anemia affected nearly 2 billion people in 2021, impacting women to a greater degree than men. In a new study covering three decades of global anemia data (1990–2021), a complex picture emerges of how several key factors play into the divergence in success stories among men, women, and children. Published in The Lancet Haematology, the study was conducted by the […]

Continue reading »

Experts call for e-cig curbs to stop child vaping

Vaping: Dr Sara outlines the main side effects Experts have called for tougher curbs on e-cigarette marketing after a survey found children were increasingly being exposed to displays in shops. They want vaping products put out of sight from minors. Two-thirds of teens aged 11 to 18 said they had seen vapes in supermarkets last year, up from 57 percent […]

Continue reading »

Study: Booster dose of mRNA COVID vaccine prompts strong T cell response in immunocompromised patients

People with an impaired immune system can achieve a relatively robust response against SARS-CoV-2 if they get a booster shot, scientists in Sweden have found in a clinical trial that administered extra mRNA shots to patients whose immunity was comprised by age, cancer, HIV and other conditions. A team at the Karolinska Institutet in Stockholm tackled one of the larger […]

Continue reading »

FDA approves Xdemvy for Demodex blepharitis

The U.S. Food and Drug Administration has approved Xdemvy (lotilaner ophthalmic solution) 0.25 percent for the treatment of Demodex blepharitis, caused by Demodex mites. The approval was based on results from two randomized, vehicle-controlled studies (Saturn-1 and Saturn-2) in which 833 patients were randomly assigned (1:1) to either Xdemvy or vehicle twice daily in each eye for six weeks. The […]

Continue reading »
1 85 86 87 88 89 1,322